cGxP.wire https://validator.w3.org/feed/docs/rss2.html Avenzo to Present AVZO-023 Phase 1 Results at SABCS 2026 Immunome Receives EMA Validation for Varegacestat Application Propanc Advances PPC-001 Assay Development for Phase 1b Cancer Study Moleculin Completes MIRACLE Trial Part A Dosing in R/R AML Atsena Reports Promising ATSN-301 Preclinical Data for Usher 1B Syndax’s Revuforj Wins 2026 Prix Galien Rare Disease Award Pelthos to Merge With Castle Creek, Expanding Skin Disease Pipeline Denali Therapeutics Wins 2026 Prix Galien Award for AVLAYAH Setara Biosciences Raises $90M Series A to Advance Rare Disease Drugs Alkermes Initiates Phase 2 Study of ALKS 7290 in Depression Latus Bio Reports Engineered AAV Capsid Data for Kidney and CNS Diseases Brainomix AI Finds Stroke Signals in CHARM Phase 3 Trial Genprex to Present TUSC2 Gene Research at GSA 2026 Meeting Formation Bio Launches $600M Fund to Advance Drug Development Agios Sets February 2027 FDA Goal Date for Mitapivat in Sickle Cell Disease Boehringer Ingelheim Launches Metabolic Matters Initiative Ascletis Reports Strong ASC30 Phase 2 Diabetes Results HERVolution Advances HERV-K Cancer Immunotherapy Research TransCode Taps Tungsten for Oncology Portfolio Review NRx Pharmaceuticals Receives FDA Approval for Preservative-Free Ketamine SetPoint Medical Performs First Boston RA Implant Procedure Novo Nordisk to Present New Wegovy Liver Research Empatica Launches WellPD for At-Home Parkinson’s Monitoring Acumen Pharmaceuticals Ends Sabirnetug Development After Phase 2 Failure Suvoda Expands Greenphire Travel to Support Trial Patients Teva Acquires BioXcel Assets to Expand Neuroscience Pipeline Leads Biolabs Doses First SLE Patient in LBL-047 Phase 1 Trial Ferring to Acquire Gameto in $1.38 Billion Deal Arrowhead Secures UK Access for REDEMPLO in FCS Alpheus Reports New Blood Biomarker Research in Glioblastoma CellsBin Wins NCI Award to Advance Myeloma Blood Test Nyra Medical Expands Leadership as CARLEN Trial Advances AcuraStem Secures $1M Award to Advance AS-241 for ALS Tangram Therapeutics Doses First Participant in Phase 1 TGM-148 Clinical Trial OneOncology Reports Outpatient Tarlatamab Safety Findings Immunocore to Present Brenetafusp Phase 1 Data at SITC 2026 Amgen to Present New Autoimmune Disease Data at ACR 2026 OSE Immunotherapeutics Reports Positive Tedopi Phase 2 Results Lynk Reports Sustained Phase III Results for Zemprocitinib Assembly Bio Doses First Participants in Phase 2 ABI-6250 Study SEKISUI Launches FDA-Cleared COVID-19 and Flu Combo Test Guardant Health Welcomes Pennsylvania Shield Screening Law aTyr Pharma Publishes Phase 3 Efzofitimod Results in Lancet Artiva Ends AlloNK Development After Safety Review Philips Launches UniGuide 3D Live Guidance for Azurion AbbVie Seeks FDA Approval for Etentamig in Myeloma Treatment Helsinn Wins UK MHRA Approval for AKYNZEO Oral Suspension Astellas and Audax Sign $1.34B DAX-044 Cancer Drug Deal Element Biosciences Launches CE-Marked AVITI Dx in Europe Kelun Advances Sac-TMT for PD-L1-Negative Lung Cancer